A four-condition crossover design (hydromorphone, dronabinol, combination, placebo) in 21 participants showed no additive or ...

Baseline stool metagenomic profiling in CheckMate 915 linked specific bacterial taxa with recurrence-free survival after ...

An emergency stay preserves current FDA-era telehealth dispensing practices for mifepristone while the Supreme Court ...

Tevimbra/Ziihera as a first-line treatment for advanced cancers of the stomach, gastroesophageal junction, and esophagus. The ...

Bipartisan legislative momentum and expanding litigation are accelerating PBM-focused reform at federal and state levels, ...

The pharmaceutical industry is entering an era of mega-blockbusters, drugs with annual sales of $10 billion or more, that ...

The ACA individual exchange exit is positioned as a strategic de-emphasis of a shrinking line, with no 2026 network changes ...

A high-touch specialty pharmacy program that combines pharmacist support, telehealth and value-based care reduced medical ...

National Priority Vouchers aim to shorten FDA review from ~10–12 months to ~1–2 months using collaborative multidisciplinary ...

The "direct-to" channel was a hot topic at the Asembia specialty pharmacy meeting this week in Las Vegas. The drug supply ...

In abdominoplasty, cebranopadol increased the proportion of patients requiring no opioid rescue medication versus placebo, ...

Teclistamab has a clear advantage because it was the first bispecific antibody to be approved, said Adams. Route of ...